SMTL ID : 6tkn.1 (1 other biounit)

Tankyrase 2 in complex with an inhibitor (OM-1000)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x NJH: ~{N}-[3-[4-(2-chlorophenyl)-5-pyrimidin-4-yl-1,2,4-triazol-3-yl]-1-bicyclo[1.1.1]pentanyl]pyridine-2-carboxamide(Non-covalent)

NJH.1: 20 residues within 4Å: Chain A: H.109, S.111, P.112, F.113, A.116, I.117, K.120, G.121, F.122, D.123, H.126, A.127, Y.128, G.131, G.136, I.137, Y.138, Y.149, G.152, I.153 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.113, A:F.113, A:A.116, A:I.117, A:H.126, A:Y.128, A:Y.138 Hydrogen bonds: A:D.123, A:Y.138 pi-Stacking: A:Y.138, A:Y.149

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 6 residues within 4Å: Chain A: C.159, V.161, H.162, C.167, I.169, C.170 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.159, A:H.162, A:C.167, A:C.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Waaler, J. et al., Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor. J.Med.Chem. (2020)

Release Date

2020-07-08

Peptides

Tankyrase-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Tankyrase-2

Related Entries With Identical Sequence